APTYS Pharmaceuticals

APTYS Pharmaceuticals (APTYS) is a privately-held contract research organization (CRO) established as a result of spin-off from the University of Auvergne in Clermont-Ferrand. It is involved basically in the business of contract research and drug delivery. It undertakes its research and development operations at five different laboratories. Two of these are for powders form, dry dosage forms, semi-solid and liquid dosage forms and three laboratories are dedicated for analytical development, quality control, dissolution studies and stability studies. The company provides contract research services in some of the major therapeutic areas such as opthalmology, dermatology, pneumology, gastroentrology, oncology, infectious diseases and pediatrics. APTYS offers products in different forms including tablets; inhalated forms; foams; liquid forms; semi-solid forms; implants; microspheres. The company offers services like formulation development, analytical development and support activities. APTYS is headquartered in Saint Beauzire, France.

Street: 
Biopole Clermont-Limagne
City: 
Saint Beauzire
Postcode: 
63360
Federal State : 
France
WebSite: 
aptys-pharmaceuticals.com
Fax: 
33-473-670687

Company Index Score

Current Index Score Historical Index Score
  • APTYS Pharmaceuticals currently scores 50 % in the index.
  • APTYS Pharmaceuticals is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • APTYS Pharmaceuticals is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets